Onward Medical N.V. (ONWD.BR)
EUR 4.74
(-0.21%)
EUR 4.74
(-0.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 936 Thousand EUR | 4826.32% |
| 2022 | 19 Thousand EUR | -93.6% |
| 2021 | 297 Thousand EUR | 1385.0% |
| 2020 | 20 Thousand EUR | 42.86% |
| 2019 | 14 Thousand EUR | 0.0% |
| 2018 | - EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2023 Q4 | 936 Thousand EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 FY | 936 Thousand EUR | 4826.32% |
| 2023 Q3 | - EUR | 0.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q3 | - EUR | 0.0% |
| 2022 Q2 | - EUR | 0.0% |
| 2022 Q4 | 19 Thousand EUR | 0.0% |
| 2022 Q1 | - EUR | 0.0% |
| 2022 FY | 19 Thousand EUR | -93.6% |
| 2021 Q4 | - EUR | 0.0% |
| 2021 FY | 297 Thousand EUR | 1385.0% |
| 2021 Q3 | - EUR | 0.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2021 Q1 | - EUR | 0.0% |
| 2020 Q4 | - EUR | 0.0% |
| 2020 Q3 | - EUR | 0.0% |
| 2020 Q1 | - EUR | 0.0% |
| 2020 FY | 20 Thousand EUR | 42.86% |
| 2019 FY | 14 Thousand EUR | 0.0% |
| 2018 FY | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | -323.529% |
| ABIVAX Société Anonyme | 1.00 EUR | -93599900.0% |
| Adocia SA | 272 Thousand EUR | -244.118% |
| Aelis Farma SA | 53 Thousand EUR | -1666.038% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 46.238% |
| genOway Société anonyme | 982.75 Thousand EUR | 4.757% |
| IntegraGen SA | 311.44 Thousand EUR | -200.531% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | -468.575% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 184.427% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 23.565% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 885.393% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -928.571% |
| Valbiotis SA | 1 Million EUR | 6.866% |
| TheraVet SA | 123.34 Thousand EUR | -658.866% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -93599900.0% |
| argenx SE | 281.12 Million EUR | 99.667% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 25.714% |
| DBV Technologies S.A. | 1.00 USD | -93599900.0% |
| Galapagos NV | 73.97 Million EUR | 98.735% |
| Genfit S.A. | 4000.00 EUR | -23300.0% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -93599900.0% |
| Innate Pharma S.A. | 1.00 EUR | -93599900.0% |
| Inventiva S.A. | 417 Thousand EUR | -124.46% |
| MaaT Pharma SA | 190 Thousand EUR | -392.632% |
| MedinCell S.A. | -6.71 Million EUR | 113.941% |
| Nanobiotix S.A. | 200 Thousand EUR | -368.0% |
| Oryzon Genomics S.A. | 6029.00 EUR | -15424.963% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | -631.25% |
| Pharming Group N.V. | 51.38 Million EUR | 98.178% |
| Poxel S.A. | 2.95 Million EUR | 68.336% |
| GenSight Biologics S.A. | 1.00 EUR | -93599900.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.909% |
| Valneva SE | 44.46 Million EUR | 97.895% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -93599900.0% |